X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (152042) 152042
Newsletter (19900) 19900
Publication (9285) 9285
Newspaper Article (7587) 7587
Book Review (1810) 1810
Magazine Article (1447) 1447
Book Chapter (611) 611
Trade Publication Article (452) 452
Web Resource (431) 431
Conference Proceeding (326) 326
Dissertation (206) 206
Book / eBook (168) 168
Reference (77) 77
Transcript (57) 57
Data Set (28) 28
Government Document (20) 20
Paper (19) 19
Report (13) 13
Journal / eJournal (10) 10
Streaming Video (7) 7
Presentation (2) 2
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (90990) 90990
male (55818) 55818
animals (49208) 49208
index medicus (48750) 48750
female (45779) 45779
anti-inflammatory agents - therapeutic use (32189) 32189
anti-inflammatory drugs (29256) 29256
nonsteroidal anti-inflammatory drugs (28749) 28749
adult (26229) 26229
middle aged (24909) 24909
anti-inflammatory agents, non-steroidal - therapeutic use (24569) 24569
pharmacology & pharmacy (22848) 22848
anti-inflammatory agents - pharmacology (22668) 22668
inflammation (20573) 20573
rats (20041) 20041
mice (19451) 19451
research (18836) 18836
aged (17449) 17449
anti-inflammatory agents, non-steroidal - pharmacology (16176) 16176
anti-inflammatory agents, non-steroidal - adverse effects (14388) 14388
anti-inflammatory agents - administration & dosage (13771) 13771
treatment outcome (13499) 13499
analysis (13125) 13125
anti-inflammatory agents, non-steroidal - administration & dosage (11533) 11533
care and treatment (9721) 9721
dose-response relationship, drug (9051) 9051
adolescent (8921) 8921
pain (8826) 8826
chemistry, medicinal (8144) 8144
risk factors (8038) 8038
drugs (7913) 7913
time factors (7713) 7713
nonsteroidal antiinflammatory drugs (7706) 7706
immunology (7580) 7580
disease models, animal (7568) 7568
drug therapy (7402) 7402
reports (7119) 7119
health aspects (7054) 7054
expression (6888) 6888
anti-inflammatory (6773) 6773
drug therapy, combination (6662) 6662
anti-inflammatory agents - adverse effects (6585) 6585
inflammation - drug therapy (6513) 6513
medicine, general & internal (6495) 6495
analgesics (6434) 6434
biochemistry & molecular biology (6371) 6371
child (6344) 6344
double-blind method (6272) 6272
gastroenterology & hepatology (6193) 6193
rheumatology (6085) 6085
administration, topical (6062) 6062
cytokines (6061) 6061
arthritis (5884) 5884
rats, wistar (5870) 5870
surgery (5569) 5569
cancer (5502) 5502
aspirin (5379) 5379
rats, sprague-dawley (5323) 5323
inhibition (5289) 5289
therapy (5103) 5103
cells, cultured (5037) 5037
arthritis, rheumatoid - drug therapy (5007) 5007
disease (4898) 4898
medical research (4870) 4870
anti-inflammatory agents, non-steroidal - chemistry (4850) 4850
oxidative stress (4729) 4729
rheumatoid-arthritis (4647) 4647
activation (4639) 4639
administration, oral (4625) 4625
double-blind (4615) 4615
aged, 80 and over (4613) 4613
cells (4581) 4581
nf-kappa-b (4536) 4536
anti-inflammatory agents - chemistry (4529) 4529
cell line (4501) 4501
plant extracts - pharmacology (4486) 4486
antioxidants (4473) 4473
corticosteroids (4418) 4418
apoptosis (4386) 4386
in-vitro (4359) 4359
medicine & public health (4337) 4337
prospective studies (4285) 4285
macrophages (4274) 4274
anti-inflammatory agents (4238) 4238
neurosciences (4194) 4194
prevention (4188) 4188
dermatology (4185) 4185
steroids (3987) 3987
cell biology (3923) 3923
dosage and administration (3892) 3892
retrospective studies (3888) 3888
medicine (3868) 3868
young adult (3827) 3827
nitric oxide (3809) 3809
osteoarthritis (3784) 3784
studies (3761) 3761
medicine, experimental (3721) 3721
follow-up studies (3687) 3687
ibuprofen (3687) 3687
research article (3641) 3641
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (129) 129
Online Resources - Online (51) 51
Collection Dvlpm't (Acquisitions) - Closed Orders (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
UofT at Mississauga - Stacks (5) 5
Sunnybrook Health Sciences Centre - Holland Stacks (3) 3
UTL at Downsview - May be requested (3) 3
UofT at Scarborough - Stacks (3) 3
Engineering & Comp. Sci. - Stacks (1) 1
Media Commons - Audio Visual (1) 1
Mt Sinai Hospital - Online (1) 1
Robarts - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (166830) 166830
German (3502) 3502
French (2997) 2997
Japanese (2030) 2030
Russian (1747) 1747
Chinese (1062) 1062
Spanish (921) 921
Italian (676) 676
Polish (672) 672
Portuguese (274) 274
Dutch (262) 262
Danish (234) 234
Korean (214) 214
Czech (165) 165
Hungarian (163) 163
Swedish (159) 159
Norwegian (140) 140
Croatian (107) 107
Romanian (93) 93
Turkish (89) 89
Ukrainian (83) 83
Finnish (80) 80
Bulgarian (60) 60
Hebrew (54) 54
Slovak (53) 53
Serbian (39) 39
Lithuanian (21) 21
Arabic (8) 8
Bosnian (8) 8
Greek (4) 4
Slovenian (4) 4
Icelandic (3) 3
Persian (3) 3
Afrikaans (2) 2
Malay (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Pharmacy and Therapeutics, ISSN 0269-4727, 04/2017, Volume 42, Issue 2, pp. 228 - 233
Summary What is known and objective There are few studies examining both drug–drug and drug–disease interactions in older adults. Therefore, the objective of... 
aged | drug interaction | drug utilization | INAPPROPRIATE MEDICATION USE | OUTPATIENTS | RISK | PHARMACOLOGY & PHARMACY | ELDERLY-PEOPLE | HEALTH | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Drug Interactions | Cross-Sectional Studies | Humans | Female | Male | Aged | Drugs | Prescribing | Fluocinolone acetonide | Drug interactions | Prevalence studies (Epidemiology)
Journal Article
1971, ISBN 0306304953, xxii, 506
Book
Inflammation & allergy, ISSN 1871-5281, 2006
Journal
2005, Progress in inflammation research, ISBN 3764365951, xiii, 343
This book gives a comprehensive overview of disease-modifying antirheumatic drugs (DMARDs). The introductory general chapters deal with the chemistry of... 
Chemotherapy | Rheumatoid arthritis | Antirheumatic agents | Clinical & internal medicine | Medicine & Public Health | Medicine/Public Health, general
Book
Allergy, ISSN 0105-4538, 07/2011, Volume 66, Issue 7, pp. 818 - 829
Journal Article
Acta Pharmaceutica Sinica B, ISSN 2211-3835, 09/2016, Volume 6, Issue 5, pp. 363 - 373
The kidney is a vital organ for the elimination of therapeutic drugs and their metabolites. Renal drug transporters, which are primarily located in the renal... 
Organic cations | Organic anions | Drug-drug interactions | Nephrotoxicity | Renal drug transporters | ORGANIC ANION TRANSPORTER | MULTIDRUG-RESISTANCE PROTEINS | KIDNEY PROXIMAL TUBULES | CISPLATIN-INDUCED NEPHROTOXICITY | FUNCTIONAL-CHARACTERIZATION | CLINICAL PHARMACOKINETICS | INTESTINAL P-GLYCOPROTEIN | CATION TRANSPORTER-2 | MOLECULAR-IDENTIFICATION | TISSUE DISTRIBUTION | PHARMACOLOGY & PHARMACY | NSAID, non-steroidal anti-inflammatory drugs | CHO, Chinese hamster ovary | URAT, urate transporter | P-gp, P-glycoprotein | GSH, glutathione | DDIs, drug–drug interactions | HEK, human embryonic kidney | IC50, half maximal inhibitory concentration | SNP, single-nucleotide polymorphism | Review | Cmax, maximum plasma concentration | MPP+, 1-methyl-4-phenylpyridimium | OCTN, Organic zwitterions | SLC, solute carrier | TEA, tetraethylammonium | ABC, ATP-binding cassette | AUC, area under the plasma concentration curve | MRP, multidrug resistance-associated protein | NBD, nucleotide-binding domain | Drug–drug interactions | ITC, International Transporter Consortium | OA, organic anion | OAT or Oat, organic anion transporters | OC, organic cation | ATP, adenosine triphosphate | TMD, transmembrane domain | CL, plasma clearance | FDA, U.S. Food and Drug Administration | MSD, membrane-spanning domain | MW, molecular weight | NME, new molecular entity | BBB, blood–brain barrier | cation transporters | PAH, p-aminohippurate | Ki, inhibitory constant | OATP or Oatp, organic anion-transporting peptide | fe, fraction of the absorbed dose excreted unchanged in urine | MATE, multidrug and toxin extrusion protein | CLR, renal clearance | OCT or Oct, organic cation transporter
Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 09/2017, Volume 139, pp. 71 - 81
has long been part of the traditional herbal medicine system in Asia and in Scandinavia. Andrographolide was isolated as a major bioactive constituent of in... 
Hepatitis | NF-κB | Autoimmune | Neurodegeneration | Nrf2 | Asthma | OXIDATIVE STRESS | ALZHEIMERS-DISEASE | COGNITIVE IMPAIRMENT | CELL-CYCLE ARREST | PROTECTIVE ACTIVITY | IN-VITRO | NF-kappa B | INDUCED PULMONARY-FIBROSIS | SIGNALING PATHWAY | PHARMACOLOGY & PHARMACY | COMBINATION KAN-JANG | NF-KAPPA-B | Liver Cirrhosis - immunology | Humans | Drugs, Investigational - therapeutic use | NF-E2-Related Factor 2 - agonists | Protective Agents - chemistry | Neurodegenerative Diseases - drug therapy | Hepatitis - drug therapy | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Hepatitis - metabolism | Pneumonia - immunology | Autoimmune Diseases - metabolism | Autoimmune Diseases - drug therapy | Diterpenes - pharmacology | Chemical and Drug Induced Liver Injury - prevention & control | NF-kappa B p50 Subunit - antagonists & inhibitors | NF-kappa B p50 Subunit - metabolism | Autoimmune Diseases - prevention & control | Chemical and Drug Induced Liver Injury - immunology | Signal Transduction - drug effects | Chemical and Drug Induced Liver Injury - metabolism | Models, Biological | NF-E2-Related Factor 2 - metabolism | Oxidative Stress - drug effects | Pneumonia - metabolism | Drugs, Investigational - adverse effects | Drugs, Investigational - pharmacology | Dermatitis - immunology | Neurodegenerative Diseases - prevention & control | Protective Agents - metabolism | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Hypoxia-Inducible Factor 1, alpha Subunit - antagonists & inhibitors | Protective Agents - therapeutic use | Neurodegenerative Diseases - immunology | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Drugs, Investigational - chemistry | Hepatitis - prevention & control | Drug Design | Liver Cirrhosis - metabolism | Diterpenes - chemistry | Liver Cirrhosis - drug therapy | Diterpenes - therapeutic use | Liver Cirrhosis - prevention & control | Autoimmune Diseases - immunology | Dermatitis - prevention & control | Neurodegenerative Diseases - metabolism | Animals | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Pneumonia - drug therapy | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | NF-kappa B p50 Subunit - chemistry | Hepatitis - immunology | Diterpenes - adverse effects | Dermatitis - drug therapy | Dermatitis - metabolism | Antioxidants | Medical colleges | Lead compounds | Drug discovery | Anti-inflammatory drugs | Analysis | Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9678, pp. 1905 - 1917
Summary Glucocorticoid resistance or insensitivity is a major barrier to the treatment of several common inflammatory diseases—including chronic obstructive... 
Internal Medicine | RHEUMATOID-ARTHRITIS | MEDICINE, GENERAL & INTERNAL | OBSTRUCTIVE PULMONARY-DISEASE | HISTONE DEACETYLASE ACTIVITY | MIGRATION INHIBITORY FACTOR | ULCERATIVE-COLITIS | REGULATORY T-CELLS | RECEPTOR-BETA | RELATIVE CORTICOSTEROID INSENSITIVITY | BLOOD MONONUCLEAR-CELLS | RESPIRATORY-DISTRESS-SYNDROME | Transcription Factor AP-1 - drug effects | Glucocorticoids - therapeutic use | Transcriptional Activation - genetics | Transcription Factor AP-1 - genetics | Humans | Macrophage Migration-Inhibitory Factors - immunology | Transcriptional Activation - drug effects | Transcription Factor AP-1 - immunology | Histone Deacetylases - immunology | Transcriptional Activation - immunology | ATP-Binding Cassette, Sub-Family B, Member 1 - drug effects | Calcineurin Inhibitors | Macrophage Migration-Inhibitory Factors - genetics | Inflammation - drug therapy | Phosphodiesterase 4 Inhibitors | Anti-Inflammatory Agents - therapeutic use | Mitogen-Activated Protein Kinases - immunology | Genetic Predisposition to Disease - genetics | NF-kappa B - antagonists & inhibitors | Histone Deacetylases - genetics | Macrophage Migration-Inhibitory Factors - drug effects | Repressor Proteins - genetics | Histone Deacetylase 2 | Drug Resistance - drug effects | Inflammation - immunology | Asthma - drug therapy | ATP-Binding Cassette, Sub-Family B, Member 1 - immunology | Drug Resistance - genetics | ATP-Binding Cassette, Sub-Family B, Member 1 - genetics | Drug Resistance - immunology | Repressor Proteins - immunology | Histone Deacetylases - drug effects | Mitogen-Activated Protein Kinases - genetics | Repressor Proteins - drug effects | Mitogen-Activated Protein Kinases - drug effects | Pulmonary Disease, Chronic Obstructive - drug therapy | Corticosteroids | Dosage and administration | Inflammation | Research | Drug resistance | Drug therapy | Health aspects | Complications and side effects | Risk factors | Inflammatory bowel disease | Proteins | Respiratory distress syndrome | Asthma | Steroids
Journal Article